Narcolepsy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
Conditions:   Narcolepsy;   Cataplexy;   Excessive Daytime Sleepiness Interventions:   Drug: AXS-12 (reboxetine);   Drug: Placebo Sponsor:   Axsome Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2021 Category: Research Source Type: clinical trials

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
Conditions:   Narcolepsy With Cataplexy;   Narcolepsy;   Narcolepsy Without Cataplexy Intervention:   Drug: Mazindol Sponsor:   NLS Pharmaceutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2021 Category: Research Source Type: clinical trials